A distinct subset of glioma displaying DNA hypermethylation, i.e., glioma-CpG island methylator phenotype (G-CIMP), has a characteristic profile; it is more prevalent among lower grade glioma, strongly associated with IDH1 mutation, diagnosed at a younger age, and has a significantly better prognosis [18]. The gene discussed is IDH1; the disease is central nervous system cancer.